文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

脓毒症相关左心室功能障碍的医院存活者中新发心力衰竭与死亡率

New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction.
PubMed 文献 · Shock · 2018-01-01
一句话结论严重脓毒症和脓毒性休克存活者中,新发左心室功能障碍未增加2年心力衰竭住院与全因死亡复合终点风险(P=0.24)。

本研究为回顾性队列研究,纳入2007至2014年间严重脓毒症和脓毒性休克成人患者,入ICU 72小时内行超声心动图,排除既往心衰、左心室功能障碍及结构性心脏病者。左心室收缩功能障碍定义为左心室射血分数<50%,舒张功能障碍定义为≥II级。共纳入434例,206例(48%)存在左心室功能障碍;331例医院存活者中,新发急性失代偿性心力衰竭住院率两组无差异(15% vs 11%),2年主要复合终点(心衰住院+全因死亡)两组相当(P=0.24),28%医院存活者随访超声显示持续性左心室功能障碍。结论:新发左心室功能障碍未增加长期不良心衰结局风险。

要点

  • 严重脓毒症/脓毒性休克成人中,48%(206/434)在入ICU 72小时内超声发现左心室功能障碍(收缩LVEF<50%或舒张≥II级)。
  • 331例医院存活者中,新发急性失代偿性心衰住院率在左心室功能障碍组与无功能障碍组分别为15%和11%,无显著差异。
  • 2年主要复合终点(心衰住院+全因死亡)在有无左心室功能障碍两组间相当(P=0.24)。
  • 医院存活者随访超声显示28%存在持续性左心室功能障碍。
  • 医院死亡率与住院时间等次要终点两组相似。

适用人群与场景

  • 2007至2014年间严重脓毒症和脓毒性休克成人患者,入ICU 72小时内行超声心动图。
  • 排除既往心力衰竭、左心室功能障碍及结构性心脏病患者。

诊断标准与关键阈值

  • 左心室收缩功能障碍:左心室射血分数<50%。
  • 左心室舒张功能障碍:≥II级。
  • 主要复合终点:2年随访期间新发急性失代偿性心力衰竭住院和全因死亡。

研究设计与关键结果

  • 回顾性队列研究,8年间纳入434例,其中206例(48%)存在左心室功能障碍。
  • 两组基线特征相似,但左心室功能障碍组左心室射血分数、心脏指数及左心室舒张功能障碍更差。
  • 331例医院存活者中,新发急性失代偿性心力衰竭住院率两组分别为15%和11%,无差异。
  • 2年主要复合终点在有无左心室功能障碍两组间相当(P=0.24)。
  • 28%医院存活者随访超声显示持续性左心室功能障碍。
  • 医院死亡率与住院时间等次要终点两组相似。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于严重脓毒症和脓毒性休克成人患者,入ICU 72小时内超声发现的新发左心室功能障碍(LVEF<50%或舒张≥II级)未增加2年心衰住院与全因死亡复合终点风险。
  • 作者认为,严重脓毒症和脓毒性休克患者中新发左心室功能障碍不增加长期不良心力衰竭结局风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The association between new-onset left ventricular (LV) dysfunction during sepsis with long-term heart failure outcomes is lesser understood.

METHODS: Retrospective cohort study of all adult patients with severe sepsis and septic shock between 2007 and 2014 who underwent echocardiography within 72 h of admission to the intensive care unit. Patients with prior heart failure, LV dysfunction, and structural heart disease were excluded. LV systolic dysfunction was defined as LV ejection fraction <50% and LV diastolic dysfunction as ≥grade II. Primary composite outcome included new hospitalization for acute decompensated heart failure and all-cause mortality at 2-year follow-up. Secondary outcomes included persistent LV dysfunction, and hospital mortality and length of stay.

RESULTS: During this 8-year period, 434 patients with 206 (48%) patients having LV dysfunction were included. The two groups had similar baseline characteristics, but those with LV dysfunction had worse function as demonstrated by worse LV ejection fraction, cardiac index, and LV diastolic dysfunction. In the 331 hospital survivors, new-onset acute decompensated heart failure hospitalization did not differ between the two cohorts (15% vs. 11%). The primary composite outcome was comparable at 2-year follow-up between the groups with and without LV dysfunction (P = 0.24). Persistent LV dysfunction was noted in 28% hospital survivors on follow-up echocardiography. Other secondary outcomes were similar between the two groups.

CONCLUSIONS: In patients with severe sepsis and septic shock, the presence of new-onset LV dysfunction did not increase the risk of long-term adverse heart failure outcomes.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Vallabhajosyula S, Jentzer JC, Geske JB, et al. New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction. Shock. 2018. PMID: 28727607. doi:10.1097/SHK.0000000000000952

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。